Kindermann, A.

patient treatment disease response ifx treatment fliximab study adjustment paediatric crohn flammatory bowel disease follow-up maintenance month bowel therapy ifx failure paediatric cd patients infusion netherland children three-dose induction scheme aliment pharmacol dosing outcome ifx therapy duration disease duration treatment schedule fliximab maintenance treatment infliximab failure surgery ef ficacy 5 years flammatory requirement induction treatment outcome effect cohort follow-up period ifx requirement maintenance treatment diagnosis analysis infection gastroenterol schedule fliximab treatment adult hospital pharmacol aliment disease location factor paediatric cd ifx maintenance therapy scheme ifx maintenance treatment location center 3 years ifx infusions dose adjustments paediatric gastroenterologists 3 months publishing blackwell range stula difference 243–250 treatment strategies bene fit three-dose discontinuation antibody period reaction